In vitro data using LY294002, an inhibitor of the DNA DSB detector DNA-dependent protein kinase (DNA-PKcs) [52], in combination with cisplatin increased cytotoxicity in the glioma cell line U343 [53]. Here, PRKDC is linked to central nervous system cancer.